Cariprazine Relative to Placebo in the Prevention of Relapse of Symptoms in Patients With Schizophrenia

Mise à jour : Il y a 4 ans
Référence : NCT01412060

Femme et Homme

Extrait

The objective of this study is to evaluate the efficacy and safety of cariprazine relative to placebo in the prevention of relapse of symptoms in patients with schizophrenia.


Critère d'inclusion

  • Schizophrenia